초록 ▼

A drug delivery apparatus comprising: a drug delivery device for selectively delivering drug-laden air or air not laden with the drug; a sensor for monitoring the breathing pattern of a patient; a controller arranged to control the drug delivery device to deliver drug-laden air in pulses which begin

A drug delivery apparatus comprising: a drug delivery device for selectively delivering drug-laden air or air not laden with the drug; a sensor for monitoring the breathing pattern of a patient; a controller arranged to control the drug delivery device to deliver drug-laden air in pulses which begin when the patient is monitored by the sensor to begin inhalation, the pulses having a duration which is adjusted by the controller on the basis of the monitored breathing pattern of the patient; a feedback indicator which indicates to a patient whether the monitored breathing pattern is effective for inhaling drug-laden air or not a dose calculator which calculates the dose delivered to the patient; and an indicator which indicates to the patient when a desired dose has been delivered, whereby the apparatus is configured to deliver the full amount of the desired dose in at least 80% of treatments.

대표청구항 ▼

1. A drug delivery apparatus comprising: a drug delivery device for selectively delivering drug-laden air or air not laden with the drug;a sensor for monitoring a breathing pattern of a patient;a controller arranged to control the drug delivery device based on a length of at least one previous inhal

1. A drug delivery apparatus comprising: a drug delivery device for selectively delivering drug-laden air or air not laden with the drug;a sensor for monitoring a breathing pattern of a patient;a controller arranged to control the drug delivery device based on a length of at least one previous inhalation of the patient to deliver drug-laden air in pulses which begin when the patient is monitored by the sensor to begin inhalation, the pulses having a duration which is adjusted by the controller on the basis of the monitored breathing pattern of the patient and the length of the at least one previous inhalation, wherein the pulse duration is determined based upon a tidal volume and an end volume of the patient, and wherein if a monitored inhalation is not suitable for drug delivery the controller controls the drug delivery device to abort a pulse corresponding to the monitored inhalation;a feedback indicator which indicates to the patient whether a pulse of drug-laden air is currently being delivered;a dose calculator which calculates a dose delivered to the patient;an indicator which indicates to the patient when a desired dose has been delivered; anda drug formulation in which NaCl and tobramycin are dissolved in a solvent, wherein a delivery efficiency of the drug formulation is at least 80 percent. 2. The drug delivery apparatus according to claim 1, wherein the drug formulation includes about 19 mg tobramycin and the solvent is about 0.3 ml in volume. 3. The drug delivery apparatus according to claim 1, wherein the drug formulation further comprises an additional amount of between about 6 and 50 mg tobramycin in about 0.1 to 0.8 ml solution which fills a dead volume of the delivery apparatus and which is residual once all of the drug which can be delivered has been delivered. 4. The drug delivery apparatus according to claim 1, wherein the concentration of tobramycin is about 60 mg/ml. 5. A drug delivery apparatus comprising: a drug delivery device for selectively delivering drug-laden air or air not laden with the drug;a sensor for monitoring a breathing pattern of a patient;a controller arranged to control the drug delivery device based on a length of at least one previous inhalation of the patient to deliver drug-laden air in pulses which begin when the patient is monitored by the sensor to begin inhalation, the pulses having a duration which is adjusted by the controller on the basis of the monitored breathing pattern of the patient and the length of the at least one previous inhalation, wherein the pulse duration is determined based upon a tidal volume and an end volume of the patient;a feedback indicator which indicates to the patient whether the monitored breathing pattern is effective for inhaling drug-laden air or not;a dose calculator which calculates a dose delivered to the patient;an indicator which indicates to the patient when a desired dose has been delivered; anda drug formulation including Alpha 1 Antitrypsin in an aqueous solution, wherein a delivery efficiency of the drug formulation is at least 80 percent. 6. The drug delivery apparatus according to claim 5, wherein the drug formulation includes about 12.5 mg Alpha 1 Antitrypsin and the aqueous solution has a volume of about 0.25 ml. 7. The drug delivery apparatus according to claim 6, wherein the drug formulation further includes an additional amount of between 0.1 ml and 0.8 ml of solvent. 8. A drug delivery apparatus comprising: a drug delivery device for selectively delivering drug-laden air or air not laden with the drug;a sensor for monitoring a breathing pattern of a patient;a controller arranged to control the drug delivery device based on a length of at least one previous inhalation of the patient to deliver drug-laden air in pulses which begin when the patient is monitored by the sensor to begin inhalation, the pulses having a duration which is adjusted by the controller on the basis of the monitored breathing pattern of the patient and the length of the at least one previous inhalation, wherein the pulse duration is determined based upon a tidal volume and an end volume of the patient, and wherein if a monitored inhalation is not suitable for drug delivery the controller will control the drug delivery device to abort a pulse corresponding to the monitored inhalation;a feedback indicator which indicates to the patient whether a pulse of drug-laden air is currently being delivered;a dose calculator which calculates a dose delivered to the patient;an indicator which indicates to the patient when a desired dose has been delivered; anda drug formulation including Budesonide in a solvent, wherein a delivery efficiency of the drug formulation is at least 80 percent. 9. The drug delivery apparatus according to claim 8, wherein the drug formulation includes about 25 μg of Budesonide and a volume of the solvent is about 0.05 ml. 10. A drug delivery apparatus comprising: a drug delivery device for selectively delivering drug-laden air or air not laden with the drug;a sensor for monitoring a breathing pattern of a patient;a controller arranged to control the drug delivery device based on a length of at least one previous inhalation of the patient to deliver drug-laden air in pulses which begin when the patient is monitored by the sensor to begin inhalation, the pulses having a duration which is adjusted by the controller on the basis of the monitored breathing pattern of the patient and the length of the at least one previous inhalation, wherein the pulse duration is determined based upon a tidal volume and an end volume of the patient, and wherein if a monitored inhalation is not suitable for drug delivery the controller will control the drug delivery device to abort a pulse corresponding to the monitored inhalation;a feedback indicator which indicates to the patient whether a pulse of drug-laden air is currently being delivered;a dose calculator which calculates a dose delivered to the patient;an indicator which indicates to the patient when a desired dose has been delivered; anda drug formulation including fluticasone in solution, wherein a delivery efficiency of the drug formulation is at least 80 percent. 11. The drug delivery device as recited in claim 1, wherein the pulse duration is calculated as: Pulse duration=mean inspiratory time×(mean tidal volume−end volume)/mean tidal volume. 12. The drug delivery device as recited in claim 5, wherein the pulse duration is calculated as: Pulse duration=mean inspiratory time×(mean tidal volume−end volume)/mean tidal volume. 13. The drug delivery device as recited in claim 8, wherein the pulse duration is calculated as: Pulse duration=mean inspiratory time×(mean tidal volume−end volume)/mean tidal volume. 14. The drug delivery device as recited in claim 10, wherein the pulse duration is calculated as: Pulse duration=mean inspiratory time×(mean tidal volume−end volume)/mean tidal volume.